You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

contiguous stage II grade 1 follicular lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytokine Release Syndrome, COVID19 Trial in Greenville (Therapeutic Plasma Exchange, Ruxolitinib)

Completed
Has Results
  • Cytokine Release Syndrome
  • COVID19
  • Greenville, South Carolina
    Prisma Health
Nov 30, 2021

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Head Neck Cancer, Head and Neck Tumors Trial in Saint Louis (CareOrbit)

Not yet recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • CareOrbit
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 10, 2023

Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's

Active, not recruiting
  • Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
  • CST-103, CST-107, matching placebo
  • Sydney, New South Wales, Australia
  • +6 more
Jun 1, 2022

Predictive Factor of Pathologic Complete Response After

Completed
  • Rectum Cancer
    • Bangkok, Bankok, Thailand
      Chairat Supsamutchai
    May 15, 2022

    Decision Making in Early Stage Prostate Cancer Patients and

    Active, not recruiting
    • Low Risk Prostate Cancer
    • assessments
    • Harrison, New York
    • +2 more
    Jan 11, 2022

    Multiple Sclerosis, Balance; Distorted Trial in Ankara (cervical mobilisation)

    Completed
    • Multiple Sclerosis
    • Balance; Distorted
    • cervical mobilisation
    • Ankara, Turkey
      Hacettepe University
    May 6, 2021

    Small Cell Lung Cancer (SCLC) Trial in France, Italy, United Kingdom (Pembrolizumab, cis/carboplatin and etoposide)

    Active, not recruiting
    • Small Cell Lung Cancer (SCLC)
    • Avignon, France
    • +18 more
    May 9, 2022

    Nonsmall Cell Lung Cancer Trial in Goyang-Si (Lorlatinib)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Goyang-Si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)

    Recruiting
    • Lung Cancer
    • Mesothelioma
    • niraparib and dostarlimab
    • Orbassano, Turin, Italy
      AOU San Luigi- Department of Oncology
    Oct 6, 2021

    Type II Diabetic Patients With and Without CAD

    Recruiting
    • Irisin Gene Polymorphism in Type II Diabetic Patients
      • Sohag, Egypt
        Sohag uniersity hosoital
      Jul 8, 2022

      Prostate Cancer, Metabolic Syndrome, Obesity Trial (Apple Cider Vinegar, Placebo)

      Not yet recruiting
      • Prostate Cancer
      • +6 more
      • Apple Cider Vinegar
      • Placebo
      • (no location specified)
      Mar 24, 2023

      Ischemic Stroke, Post-stroke Cognitive Impairment Trial (Cromolyn, Placebo)

      Withdrawn
      • Ischemic Stroke
      • Post-stroke Cognitive Impairment
      • (no location specified)
      Feb 16, 2022

      B-cell Non Hodgkin Lymphoma Trial in Hangzhou (anti-CD19 CAR-NK)

      Recruiting
      • B-cell Non Hodgkin Lymphoma
      • anti-CD19 CAR-NK
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      May 13, 2021

      Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

      Active, not recruiting
      • Breast Cancer
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Dec 13, 2022

      Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)

      Completed
      Has Results
      • Tumor
      • Ovarian Cancer
      • NKTR-102 q14d
      • NKTR-102 q21d
      • Highland, California
      • +19 more
      Jul 9, 2021

      Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

      Recruiting
      • Multiple Sclerosis
      • 18F-florbetaben PET/CT
      • Pavia, PV, Italy
        ICS Maugeri SpA SB IRCCS
      Mar 23, 2023

      Primary Open Angle Glaucoma Trial in Sohag

      Not yet recruiting
      • Primary Open Angle Glaucoma
        • Sohag, Egypt
          Sohag University hospitals
        Apr 27, 2022

        Breast Cancer Female, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial in Kampala

        Completed
        • Breast Cancer Female
        • +11 more
        • Kampala, Uganda
        • +1 more
        Jun 7, 2022

        Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)

        Recruiting
        • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
        • Guangzhou, Guangdong, China
          Department of Medical Oncology, Sun Yat-sen University Cancer Ce
        Mar 12, 2021

        Peripheral Arterial Disease Trial in Leuven (Walking, Control)

        Completed
        • Peripheral Arterial Disease
        • Walking
        • Control
        • Leuven, Belgium
          KU Leuven
        Mar 7, 2022

        Progesterone Resistance Trial in Abu Dhabi (follicle stimulating hormone)

        Completed
        • Progesterone Resistance
        • follicle stimulating hormone
        • Abu Dhabi, United Arab Emirates
          IVI Middle East Fertilty Clinic
        Sep 8, 2020

        Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma Trial in Toronto (Robotic Retroperitoneal Lymph Node Dissection

        Recruiting
        • Lymphadenopathy Retroperitoneal
        • Stage II Testicular Seminoma
        • Robotic Retroperitoneal Lymph Node Dissection (RPLND)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        May 16, 2022

        Violence, Emotional Adjustment Trial in London (Face It, Control)

        Recruiting
        • Violence
        • Emotional Adjustment
        • Face It
        • Control
        • London, United Kingdom
        • +1 more
        Sep 25, 2023

        NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Wuhan, Hubei, China
          Qian Chu
        Aug 18, 2023